Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for APRE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 12.39M
March 31, 2026 11.98M
December 31, 2025 8.192M
September 30, 2025 5.979M
June 30, 2025 5.752M
March 31, 2025 5.513M
December 31, 2024 5.481M
September 30, 2024 5.435M
June 30, 2024 5.430M
March 31, 2024 5.430M
December 31, 2023 3.737M
September 30, 2023 3.737M
June 30, 2023 3.732M
March 31, 2023 3.732M
Date Value
December 31, 2022 0.1328M
September 30, 2022 2.612M
June 30, 2022 1.170M
March 31, 2022 1.099M
December 31, 2021 1.093M
September 30, 2021 1.068M
June 30, 2021 1.059M
March 31, 2021 1.059M
December 31, 2020 1.059M
September 30, 2020 1.059M
June 30, 2020 1.059M
March 31, 2020 1.053M
December 31, 2019 1.051M
September 30, 2019 1.036M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Zymeworks, Inc. 71.96M
Rhythm Pharmaceuticals, Inc. 68.82M
Onconetix, Inc. 3.794M
ACADIA Pharmaceuticals, Inc. 172.13M
Alnylam Pharmaceuticals, Inc. 133.73M